advanced search
2023_Terumo_leaderboard

INJECTION

PRODUCTIVE SUPPLY CHAIN SYNERGIES BETWEEN OMPI & BALDA
PREFILLED SYRINGES
Paul Wismer
Stevanato Group
PRODUCTIVE SUPPLY CHAIN SYNERGIES BETWEEN OMPI & BALDA
Alessandro Artioli, Alessandro Morandotti and Paul Wismer look at the first example of integration between Ompi and Balda since Balda's acquisition by Stevanato group: the Ompi EZ-fill® Integrated Tip Cap.
AUTOMATIC NEEDLE FEEDING & AUTOMATED PRODUCTION OF READY-TO-FILL PREFILLABLE SYRINGES
PREFILLED SYRINGES
Berthold Schopferer
AUTOMATIC NEEDLE FEEDING & AUTOMATED PRODUCTION OF READY-TO-FILL PREFILLABLE SYRINGES
In this article, Harry Pruner describes the automated assembly equipment offered by ZAHORANSKY AG for the production of ready-to-fill, prefillable syringes.
PREFERRED BY PATIENTS… WITH IMPROVED THERAPIES
WEARABLES
Sandra De Haan
PREFERRED BY PATIENTS… WITH IMPROVED THERAPIES
Sandra de Haan describes how the Sensile Medical’s micro pump technology advances have enabled it to develop wearable injector patch pumps to deliver better care for patients.
DELIVERY DEVICES AS THE NEW KEY TO PRODUCT SUCCESS
WEARABLES
Dr Jeannie Joughin
Enable Injections
DELIVERY DEVICES AS THE NEW KEY TO PRODUCT SUCCESS
Jeannie Joughin describes how on-body delivery systems for the subcutaneous delivery of high volumes of viscous formulations can solve the challenges rapidly emerging as pharma companies advance their biologics pipelines.
IMPORTANCE OF ADHESIVE SELECTION IN WEARABLE DEVICES FOR DRUG DELIVERY SYSTEMS
WEARABLES
Dr Gozde Karabiyik
IMPORTANCE OF ADHESIVE SELECTION IN WEARABLE DEVICES FOR DRUG DELIVERY SYSTEMS
Gozde Karabiyik highlights the crucial role that the adhesive plays in the success of a wearable injection device, describes in detail some of the challenges relating to skin adhesives.
LARGE VOLUME INJECTION – BEYOND VOLUME AND VISCOSITY
WEARABLES
Dr James Blakemore
Cambridge Consultants
LARGE VOLUME INJECTION – BEYOND VOLUME AND VISCOSITY
James Blakemore uncovers the underlying reasons that drive the use of large volume injectors and make the case for a more extensive use of such devices based on the broader-than-expected purposes they can serve.
UNDERSTANDING THE MARKET FOR WEARABLE LARGE VOLUME INJECTORS
EXPERT VIEW
Dr Clare Beddoes
UNDERSTANDING THE MARKET FOR WEARABLE LARGE VOLUME INJECTORS
Clare Beddoes gives an overview of the exciting state of the injectables market, with a particular eye towards the new sector of wearable bolus injectors, also known as large volume injection devices.
COMPANY SHOWCASE: CANÈ MEDICAL TECHNOLOGY
WEARABLES
COMPANY SHOWCASE: CANÈ MEDICAL TECHNOLOGY
Canè SpA is a leading manufacturer of ambulatory infusion pumps for the administration of pharmaceuticals. Starting from the first syringe drivers, which were relatively bulky thus causing patient compliance to suffer to miniature pumps which may be worn without impacting patients’ normal daily routine.
AN INTRODUCTION TO YPSODOSE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS
WEARABLES
Ian Thompson
Ypsomed
AN INTRODUCTION TO YPSODOSE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS
Ian Thompson V ice-President Business Development at Ypsomed, describes self-injection device trends for larger injection volumes and introduces YpsoDose, a new prefilled large-volume wearable injector being developed by Ypsomed Delivery Systems.
A WEARABLE ENGINEERED WITH BOTH PATIENT & PHARMA PARTNER IN MIND
WEARABLES
Tom McLean
West Pharmaceutical Services
A WEARABLE ENGINEERED WITH BOTH PATIENT & PHARMA PARTNER IN MIND
Tom McLean discusses West Pharmaceutical’s wearable technology platform. SmartDose is a customer-driven, patient-centric device that was recently selected by Amgen for the Pushtronex™ system.
A BLUETOOTH-CONNECTED WEARABLE, ON-BODY INJECTOR
CONNECTIVITY
Mike Hooven
Enable Injections
A BLUETOOTH-CONNECTED WEARABLE, ON-BODY INJECTOR
In this article, we explore the vast potential for improving patient care that comes from adding connectivity to devices that deliver biotherapeutics for the treatment of chronic conditions.
MATHIAS ROMACKER, PFIZER
INTERVIEW
Mathias Romacker
MATHIAS ROMACKER, PFIZER
Mathias Romacker shares his thoughts on the emergence of connectivity in drug delivery devices, he explains why he thinks the buzz around connectivity in delivery systems is more than just hype and describes the trends in the pharma sector that mean it makes sense now to connect up devices.
COMPANY SHOWCASE: SHL
CONNECTIVITY
SHL Medical
COMPANY SHOWCASE: SHL
SHL Group, the world’s largest privately owned designer, developer and manufacturer of advanced drug delivery systems, has been recently venturing into the field of connected devices.
SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED
INTERVIEW
Simon Michel
Ypsomed
SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED
Simon Michel talks about his vision for how the connected world of drug delivery devices will evolve, and Ypsomed’s central role within it.
CONNECTED HEALTH: THE FUTURE OF EFFECTIVE DRUG DELIVERY
CONNECTIVITY
Dr Nicolas Brandes
West Pharmaceutical Services
CONNECTED HEALTH: THE FUTURE OF EFFECTIVE DRUG DELIVERY
Chris Evans and Nicolas Brandes both of West, set the company's movement into connected health in the context of trends in the pharmaceutical industry. They introduce their partnership with HealthPrize.
CONNECTED COMBINATION PRODUCTS: PAST, PRESENT & FUTURE
EXPERT VIEW
Napoleon Monroe
CONNECTED COMBINATION PRODUCTS: PAST, PRESENT & FUTURE
Napoleon Monroe provides an overview of connected health with a focus on drug delivery systems, beginning by showing that connected health has not suddenly emerged out of nowhere but, rather, it has been developing and evolving over many decades, even centuries.
THE DRUG DELIVERY DEVICE AND CONNECTIVITY CHALLENGE
CONNECTIVITY
Neil Williams
THE DRUG DELIVERY DEVICE AND CONNECTIVITY CHALLENGE
Neil Williams offers insights into the challenges and experiences of developing a complete connected system including injection device, app, cloud storage, integration engine and dashboarding tool, and what to look for in a partner, to help deliver connected health devices, apps and a strategic platform.
THE MULTIPLE VALUES OF INTEGRATED SOLUTIONS
CONNECTIVITY
Eric Dessertenne
Biocorp
THE MULTIPLE VALUES OF INTEGRATED SOLUTIONS
Arnaud Guillet and Eric Dessertenne, both of Biocorp outline the potential value of the data that can be collected from integrated devices, not only for pharma companies but also for patients and payers.
EMBRACING THE FUTURE: CONNECTED DRUG DELIVERY SOLUTIONS
CONNECTIVITY
SHL Medical
EMBRACING THE FUTURE: CONNECTED DRUG DELIVERY SOLUTIONS
SHL Group explore the opportunities that the advance of digital health can bring to pharma companies, using a connected device solution to illustrate how connectivity can improve adherence to medication.
ADVANTAGES OF USING AN ELECTRONIC INJECTOR FOR DUAL CHAMBER CARTRIDGES
DUAL CHAMBER
Bjarne Sørensen
ADVANTAGES OF USING AN ELECTRONIC INJECTOR FOR DUAL CHAMBER CARTRIDGES
Bjarne Sørensen explores the benefits offered by an alternative technology – the electronic injector – and how it can be used to incorporate likely future requirements such as connectivity and reduced packaging.
COMPANY SHOWCASE: HASELMEIER
PREFILLED SYRINGES
Volker Wirth
Haselmeier
COMPANY SHOWCASE: HASELMEIER
Haselmeier discusses its business philosophy and expands upon its range of injection pen devices.
PRODUCT SHOWCASE: PREMIUMCOAT™
INJECTION
Anne Bailly
Aptar Pharma
PRODUCT SHOWCASE: PREMIUMCOAT™
Anne Bailey discusses Aptar Stelmi's PremiumCoat™, a novel range of coated elastomeric stoppers for biopharmaceuticals.
INJECTING HUMAN FACTORS/USABILITY ENGINEERING INTO INJECTION DEVICE DESIGN
EXPERT VIEW
Dr Marc Egeth
INJECTING HUMAN FACTORS/USABILITY ENGINEERING INTO INJECTION DEVICE DESIGN
Fourth in a series of articles covering quality system requirements for medical devices used to deliver drugs and biologics and combination/borderline products, Marc Egeth, Patricia McGahern and Sarah Johnstone discuss use errors associated with marketed and in-development injection systems.
APPLYING DEVICE DESIGN CONTROL CORE PROCESSES
EXPERT VIEW
Lilli Zakarija
APPLYING DEVICE DESIGN CONTROL CORE PROCESSES
Lilli Zakarija examines the selection of off-the-shelf drug delivery devices by pharmaceutical and biologics companies.
Top